Table 1 |
||
| IC50s for human and canine osteosarcoma cell lines treated with taurolidine or doxorubicin (inhibition curves shown in Figure1) | ||
| Cell line | Taurolidine (μM) | Doxorubicin (nM) |
| Saos-2 | 150 | NR |
| D17 | 55 | 92 |
| Clone-4 | NR | 61 |
| HMPOS | 23 | 1 |
| COS | 119 | 119 |
NR = IC50 Not Reached.
Marley et al. BMC Veterinary Research 2013 9:15 doi:10.1186/1746-6148-9-15
